SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trickle Portfolio
An SI Board Since October 2000
Posts SubjectMarks Bans
1784 65 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1234From Briefing.com: >>11:29AM Invitrogen perhaps dragged down unfairly (IVtuck-10/17/2002
1233Snipped from an article in Forbes on a new fund manager chris faber. he has hadmopgcw-10/16/2002
1232MIL makes its numbers: >>BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 16, 2002--tuck-10/16/2002
1231Tuck, i would be careful writing CALP off, based on a press release only. WeatheSpekulatius-10/15/2002
1230Agilent downgraded this morning, and also this from Briefing.com: >>8:48Atuck-10/15/2002
1229Trickle has not followed Apogent for a while, but it is good to see this news frtuck-10/10/2002
1228My perception is that real estate is a bit bubbly, and that this amounts to ARE tuck-10/8/2002
1227Biotech cashes in on real estate: ZymoGenetics sells, leases back HQ By Luke Tkeokalani'nui-10/8/2002
1226<i>On the research side of things, such devices would automate processes tkeokalani'nui-10/4/2002
1225Big boom in tiny microfluidics world? depts.washington.eduMike McFarland-10/3/2002
1224No, in the long run, not great for CALP. I would guess that Fluidigm's techtuck-10/2/2002
1223You will have a better idea than I do, but this does not look great for CALP - nigel bates-9/26/2002
1222On the theory that QGENF is at all time lows, has not warned, and is usually gootuck-9/24/2002
1221Hmmm . . . based on the last line in this snipped article, BEC may indeed tuck-9/24/2002
1220<i>Other competitors are ... Aviva </i> avivabio.com <i>...Nnigel bates-9/23/2002
1219(<i>slightly</i> OT) Roll up, roll up... Mon Sep 23, by Richard Wonigel bates-9/23/2002
1218<i>already on the market?</i> Yep - metrigenix.com GLGC had 54% wnigel bates-9/20/2002
1217Interesting wrinkle in the biochip biz; already on the market? the-scientist.cotuck-9/19/2002
1216Well, they're certainly very different instruments. Thanks.scaram(o)uche-9/19/2002
1215>>why do you say by "different means"?<< >>IonWorkstuck-9/19/2002
1214why do you say by "different means"? not saying you're wrong, butscaram(o)uche-9/19/2002
1213IonWorks: >>head-to-head competitor with the Biacore/Axiom proposed entry?tuck-9/19/2002
1212>> IonWorks: MDCC has been yapping about that for a while now; let's sscaram(o)uche-9/19/2002
1211IonWorks: MDCC has been yapping about that for a while now; let's see how ittuck-9/19/2002
1210Molecular Devices Introduces IonWorks(TM) HT System for High-Throughput Ion Chanmopgcw-9/18/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News